{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:01:37Z","timestamp":1740128497002,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-023-01584-8","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T18:02:22Z","timestamp":1689616942000},"page":"833-837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential Benefit of Channel Activators in Loss-of-Function Primary Potassium Channelopathies Causing Heredoataxia"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3061-6538","authenticated-orcid":false,"given":"Jos\u00e9","family":"Gazulla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Berciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"1584_CR1","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3390\/life13061350","volume":"13","author":"H Huang","year":"2023","unstructured":"Huang H, Shakkottai VG. Targeting ion channels and Purkinje neuron intrinsic membrane excitability as a therapeutic strategy for cerebellar ataxia. Life. 2023;13:1350.","journal-title":"Life"},{"key":"1584_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1124\/molpharm.121.000478","volume":"102","author":"SR Srinivasan","year":"2022","unstructured":"Srinivasan SR, Huang H, Chang WC, Nasburg JA, Nguyen HM, Strassmaier T, et al. Discovery of novel activators of large-conductance calcium-activated potassium channels for the treatment of cerebellar ataxia. Mol Pharmacol. 2022;102:438\u201349.","journal-title":"Mol Pharmacol"},{"key":"1584_CR3","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1523\/JNEUROSCI.23-07-02600.2003","volume":"23","author":"MD Womack","year":"2003","unstructured":"Womack MD, Khodakhah K. Somatic and dendritic small-conductance calcium-activated potassium channels regulate the output of cerebellar Purkinje neurons. J Neurosci. 2003;23:2600\u20137.","journal-title":"J Neurosci"},{"key":"1584_CR4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/ana.23803","volume":"72","author":"SM Pulst","year":"2012","unstructured":"Pulst SM, Otis TS. Repolarization matters: mutations in the Kv4.3 potassium channel cause SCA19\/22. Ann Neurol. 2012;72:829\u201331.","journal-title":"Ann Neurol."},{"key":"1584_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022871","volume":"6","author":"R K\u00f6hling","year":"2016","unstructured":"K\u00f6hling R, Wolfart J. Potassium channels in epilepsy. Cold Spring Harb Perspect Med. 2016;6: a022871.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1584_CR6","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1517\/13543784.9.10.2269","volume":"9","author":"K Lawson","year":"2000","unstructured":"Lawson K. Is there a role for potassium channel openers in neuronal ion channel disorders? Expert Opin Investig Drugs. 2000;9:2269\u201380.","journal-title":"Expert Opin Investig Drugs"},{"key":"1584_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/ng1758","volume":"38","author":"MF Waters","year":"2006","unstructured":"Waters MF, Minassian NA, Stevanin G, Figueroa KP, Bannister JP, Nolte D, et al. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. Nat Genet. 2006;38:447\u201351.","journal-title":"Nat Genet"},{"key":"1584_CR8","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1113\/JP271343","volume":"594","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Kaczmarek LK. Kv3.3 potassium channels and spinocerebellar ataxia. J Physiol. 2016;594:4677\u201384.","journal-title":"J Physiol."},{"key":"1584_CR9","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1113\/jphysiol.2012.228205","volume":"590","author":"NA Minassian","year":"2012","unstructured":"Minassian NA, Lin MC, Papazian DM. Altered Kv3.3 channel gating in early-onset spinocerebellar ataxia type 13. J Physiol. 2012;590:1599\u2013614.","journal-title":"J Physiol."},{"key":"1584_CR10","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1111\/j.0953-816X.2004.03385.x","volume":"19","author":"A McMahon","year":"2004","unstructured":"McMahon A, Fowler SC, Perney TM, Akemann W, Kn\u00f6pfel T, Joho RH. Allele-dependent changes of olivocerebellar circuit properties in the absence of the voltage-gated potassium channels Kv3.1 and Kv3.3. Eur J Neurosci. 2004;19:3317\u201327.","journal-title":"Eur J Neurosci"},{"key":"1584_CR11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/ana.23700","volume":"72","author":"A Duarri","year":"2012","unstructured":"Duarri A, Jezierska J, Fokkens M, Meijer M, Schelhaas HJ, den Dunnen WF, et al. Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19. Ann Neurol. 2012;72:870\u201380.","journal-title":"Ann Neurol"},{"key":"1584_CR12","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/ana.23701","volume":"72","author":"YC Lee","year":"2012","unstructured":"Lee YC, Durr A, Majczenko K, Huang YH, Liu YC, Lien CC, et al. Mutations in KCND3 cause spinocerebellar ataxia type 22. Ann Neurol. 2012;72:859\u201369.","journal-title":"Ann Neurol"},{"key":"1584_CR13","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1523\/JNEUROSCI.5257-05.2006","volume":"26","author":"M Kollo","year":"2006","unstructured":"Kollo M, Holderith NB, Nusser Z. Novel subcellular distribution pattern of A-type K+ channels on neuronal surface. J Neurosci. 2006;26:2684\u201391.","journal-title":"J Neurosci"},{"key":"1584_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neulet.2018.02.005","volume":"688","author":"DD Bushart","year":"2019","unstructured":"Bushart DD, Shakkottai VG. Ion channel dysfunction in cerebellar ataxia. Neurosci Lett. 2019;688:41\u20138.","journal-title":"Neurosci Lett"},{"key":"1584_CR15","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.3390\/ijms21165802","volume":"21","author":"L Pollini","year":"2020","unstructured":"Pollini L, Galosi S, Tolve M, Caputi C, Carducci C, Angeloni A, et al. KCND3-related neurological disorders: from old to emerging clinical phenotypes. Int J Mol Sci. 2020;21:5802.","journal-title":"Int J Mol Sci"},{"key":"1584_CR16","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.3390\/ijms22094986","volume":"22","author":"G Zanni","year":"2021","unstructured":"Zanni G, Hsiao CT, Fu SJ, Tang CY, Capuano A, Bosco L, et al. Novel KCND3 variant underlying nonprogressive congenital ataxia or SCA19\/22 disrupt KV4.3 protein expression and K+ currents with variable effects on channel properties. Int J Mol Sci. 2021;22:4986.","journal-title":"Int J Mol Sci."},{"key":"1584_CR17","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1136\/jnnp-2012-304131","volume":"84","author":"SE Tomlinson","year":"2013","unstructured":"Tomlinson SE, Rajakulendran S, Tan SV, Graves TD, Bamiou DE, Labrum RW, et al. Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1. J Neurol Neurosurg Psychiatry. 2013;84:1107\u201312.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1584_CR18","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1212\/WNL.0000000000012870","volume":"97","author":"E Benarroch","year":"2021","unstructured":"Benarroch E. What is the role of potassium channels in ataxia? Neurology. 2021;97:938\u201342.","journal-title":"Neurology"},{"key":"1584_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.nurt.2007.01.010","volume":"4","author":"S Rajakulendran","year":"2007","unstructured":"Rajakulendran S, Schorge S, Kullmann DM, Hanna MG. Episodic ataxia type 1: a neuronal potassium channelopathy. Neurotherapeutics. 2007;4:258\u201366.","journal-title":"Neurotherapeutics"},{"key":"1584_CR20","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/emboj\/17.5.1200","volume":"17","author":"MC D'Adamo","year":"1998","unstructured":"D\u2019Adamo MC, Liu Z, Adelman JP, Maylie J, Pessia M. Episodic ataxia type-1 mutations in the hKv1.1 cytoplasmic pore region alter the gating properties of the channel. EMBO J. 1998;17:1200\u20137.","journal-title":"EMBO J."},{"key":"1584_CR21","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1038\/s41467-023-38834-6","volume":"14","author":"RW Manville","year":"2023","unstructured":"Manville RW, Alfredo Freites J, Sidlow R, Tobias DJ, Abbott GW. Native American ataxia medicines rescue ataxia-linked mutant potassium channel activity via binding to the voltage sensing domain. Nat Commun. 2023;14:3281.","journal-title":"Nat Commun"},{"key":"1584_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ana.24929","volume":"81","author":"KL Oliver","year":"2017","unstructured":"Oliver KL, Franceschetti S, Milligan CJ, Muona M, Mandelstam SA, Canafoglia L, et al. Myoclonus epilepsy and ataxia due to KCNC1 mutation: analysis of 20 cases and K+ channel properties. Ann Neurol. 2017;81:677\u201389.","journal-title":"Ann Neurol"},{"key":"1584_CR23","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1684\/epd.2020.1197","volume":"22","author":"N Barot","year":"2020","unstructured":"Barot N, Margiotta M, Nei M, Skidmore C. Progressive myoclonic epilepsy: myoclonic epilepsy and ataxia due to KCNC1 mutation (MEAK): a case report and review of the literature. Epileptic Disord. 2020;22:654\u20138.","journal-title":"Epileptic Disord"},{"key":"1584_CR24","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1073\/pnas.1920008117","volume":"117","author":"X Du","year":"2020","unstructured":"Du X, Carvalho-de-Souza JL, Wei C, Carrasquel-Ursulaez W, Lorenzo Y, Gonzalez N, et al. Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia. Proc Natl Acad Sci U S A. 2020;117:6023\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1584_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198040","volume":"13","author":"R Chopra","year":"2018","unstructured":"Chopra R, Bushart DD, Shakkottai VG. Dendritic potassium channel dysfunction may contribute to dendrite degeneration in spinocerebellar ataxia type 1. PLoS One. 2018;13: e0198040.","journal-title":"PLoS ONE"},{"key":"1584_CR26","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/brain\/awac441","volume":"146","author":"M Qui\u00f1onez","year":"2023","unstructured":"Qui\u00f1onez M, DiFranco M, Wu F, Cannon SC. Retigabine suppresses loss of force in mouse models of hypokalaemic periodic paralysis. Brain. 2023;146:1554\u201360.","journal-title":"Brain"},{"key":"1584_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12975-013-0297-7","volume":"5","author":"NH Shah","year":"2014","unstructured":"Shah NH, Aizenman E. Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration. Transl Stroke Res. 2014;5:38\u201358.","journal-title":"Transl Stroke Res"},{"key":"1584_CR28","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.3390\/ijms21082935","volume":"21","author":"MC D'Adamo","year":"2020","unstructured":"D\u2019Adamo MC, Liantonio A, Rolland JF, Pessia M, Imbrici P. Kv1.1 Channelopathies: pathophysiological mechanisms and therapeutic approaches. Int J Mol Sci. 2020;21:2935.","journal-title":"Int J Mol Sci."},{"key":"1584_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/jnnp.65.4.565","volume":"65","author":"JC Jen","year":"1998","unstructured":"Jen JC, Yue Q, Karrim J, Nelson SF, Baloh RW. Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia. J Neurol Neurosurg Psychiatry. 1998;65:565\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1584_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1034\/j.1600-0404.2001.00299.x","volume":"104","author":"I Yabe","year":"2001","unstructured":"Yabe I, Sasaki H, Yamashita I, Takei A, Tashiro K. Clinical trial of acetazolamide in SCA6, with assessment using the Ataxia Rating Scale and body stabilometry. Acta Neurol Scand. 2001;104:44\u20137.","journal-title":"Acta Neurol Scand"},{"key":"1584_CR31","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/mds.28355","volume":"36","author":"DD Bushart","year":"2021","unstructured":"Bushart DD, Huang H, Man LJ, Morrison LM, Shakkottai VG. A chlorzoxazone-baclofen combination improves cerebellar impairment in spinocerebellar ataxia type 1. Mov Disord. 2021;36:622\u201331.","journal-title":"Mov Disord"},{"key":"1584_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000367896","volume":"22","author":"M Cui","year":"2014","unstructured":"Cui M, Qin G, Yu K, Bowers MS, Zhang M. Targeting the small- and intermediate-conductance Ca-activated potassium channels: the drug-binding pocket at the channel\/calmodulin interface. Neurosignals. 2014;22:65\u201378.","journal-title":"Neurosignals"},{"key":"1584_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/acn3.527","volume":"5","author":"DD Bushart","year":"2018","unstructured":"Bushart DD, Chopra R, Singh V, Murphy GG, Wulff H, Shakkottai VG. Targeting potassium channels to treat cerebellar ataxia. Ann Clin Transl Neurol. 2018;5:297\u2013314.","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"1584_CR34","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s12311-021-01349-1","volume":"21","author":"PA Egorova","year":"2022","unstructured":"Egorova PA, Bezprozvanny IB. Electrophysiological studies support utility of positive modulators of SK channels for the treatment of spinocerebellar ataxia type 2. Cerebellum. 2022;21(5):742\u20139.","journal-title":"Cerebellum"},{"key":"1584_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1474-4422(21)00457-9","volume":"21","author":"G Coarelli","year":"2022","unstructured":"Coarelli G, Heinzmann A, Ewenczyk C, Fischer C, Chupin M, Monin ML, et al. Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2022;21:225\u201333.","journal-title":"Lancet Neurol"},{"key":"1584_CR36","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1474-4422(15)00201-X","volume":"14","author":"S Romano","year":"2015","unstructured":"Romano S, Coarelli G, Marcotulli C, Leonardi L, Piccolo F, Spadaro M, et al. Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015;14:985\u201391.","journal-title":"Lancet Neurol"},{"key":"1584_CR37","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1212\/WNL.0b013e3181d31e23","volume":"74","author":"G Ristori","year":"2010","unstructured":"Ristori G, Romano S, Visconti A, Cannoni S, Spadaro M, Frontali M, et al. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Neurology. 2010;74:839\u201345.","journal-title":"Neurology"},{"key":"1584_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/19336950.2015.1077650","volume":"9","author":"H Wulff","year":"2015","unstructured":"Wulff H, Christophersen P. Recent developments in ion channel pharmacology. Channels. 2015;9:335.","journal-title":"Channels"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-023-01584-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-023-01584-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-023-01584-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T09:20:37Z","timestamp":1710840037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-023-01584-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["1584"],"URL":"https:\/\/doi.org\/10.1007\/s12311-023-01584-8","relation":{},"ISSN":["1473-4230"],"issn-type":[{"type":"electronic","value":"1473-4230"}],"subject":[],"published":{"date-parts":[[2023,7,17]]},"assertion":[{"value":"29 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval is in accordance with the local institutional ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}